基于专利与科学文献的抗癌天然产物研究现状与热点
该研究通过检索incoPat专利库与Web of Science核心集及PubMed,共纳入20,435个专利家族和38,746篇文献,运用CiteSpace等进行可视化分析,梳理了抗癌天然产物的技术主题与学术热点。结果显示抗癌天然产物主要涉及凋亡诱导剂、拓扑异构酶抑制剂等八类,并指出中药理论对抗癌机制研究与新药开发具有指导意义。
要点
- 抗癌天然产物涵盖凋亡诱导、拓扑异构酶抑制、端粒酶抑制等八类作用机制。
- 药用植物开发与天然活性产物抗癌机制仍是研究热点,尤与免疫检查点、精油及转移性癌症相关。
- 中医理论如「以平为期」「异病同治」「归经理论」「扶正祛邪」对抗癌研究有指导意义。
核心结论
- 抗癌天然产物技术引入较早但后期发展动力不足,科研活动相对封闭,需加强技术交流。
- 药用植物开发与天然活性产物抗癌机制仍是研究热点,尤与免疫检查点、精油及转移性癌症相关。
- 中医理论对抗癌机制研究与新药开发具有重要指导意义,可提供新思路。
研究设计与样本
- 专利数据检索自incoPat专利检索数据库,论文数据检索自Web of Science核心集和PubMed。
- 共收集20,435个专利家族和38,746篇文章,检索截止日期为2022年1月4日。
- 使用GraphPad Prism 8、Microsoft Excel 2010和CiteSpace 5.8.R3进行可视化处理。
- 专利文献分析维度包括专利申请人类型、国家(或地区)和技术主题。
- 科学文章分析维度包括学术团队、学科领域、关键词聚类和突现探测。
主要发现
- 抗癌天然产物来源药物主要包括凋亡诱导剂如姜黄素、没食子酸、白藜芦醇、Theranekron D6和gaillardin。
- 拓扑异构酶抑制剂包括喜树碱类、骨架跳跃黄酮类、鬼臼毒素、oxocrebanine和吴茱萸碱衍生物。
- 端粒酶抑制剂包括喜树碱和白屈菜异喹啉生物碱、穗花杉双黄酮和大黄素。
- 微管抑制剂包括kolaflavanone、丹参酮IIA类似物、丁香酚和millepachine。
- 免疫调节剂包括岩藻聚糖、杨梅素、佛手柑内酯和白术内酯I;肿瘤微环境调节剂包括β-七叶皂苷和icaritin;多药耐药逆转剂包括小檗碱、槲皮素和二氢杨梅素;抗血管生成和抗转移剂包括表没食子儿茶素-3-没食子酸酯、羽扇豆醇、芒柄花苷和柴胡皂苷A。
关键数值与推荐
- 共纳入20,435个专利家族和38,746篇文章,检索截止日期为2022年1月4日。
- 专利分析涵盖申请人类型、国家(或地区)和技术主题;文章分析涵盖学术团队、学科领域、关键词聚类和突现探测。
临床怎么用
- 关注凋亡诱导、拓扑异构酶抑制、端粒酶抑制、微管抑制、免疫调节、肿瘤微环境调节、多药耐药逆转及抗血管生成与抗转移等八类天然产物抗癌机制。
- 在抗癌天然产物研究中可结合中医「以平为期」「异病同治」「归经理论」「扶正祛邪」等理论指导机制研究与新药开发。
- 加强科研技术交流,关注免疫检查点、精油及转移性癌症相关研究方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The patent literature contains a large amount of information on the internal state of current industrial technologies that are not available in other literature studies. Scientific articles are the direct achievements of theoretical research in this field and can reveal how current theories in basic research have developed. In this study, the progress and status of natural anticancer products in this field were summarized, and the research hotspots were explored through the analysis of the relevant patent literature and scientific articles. Methods: Patent data were retrieved from the incoPat patent retrieval database, and paper data were retrieved from the Web of Science core set and PubMed. GraphPad Prism 8, Microsoft Excel 2010, and CiteSpace 5.8.R3 were used to perform visual processing. The analyzed patent literature includes the patent applicant type, country (or region), and technical subject. The analyzed scientific article includes academic groups, subject areas, keyword clustering, and burst detection. Results: A total of 20,435 patent families and 38,746 articles were collected by 4 January 2022. At present, antitumor drugs derived from natural products mainly include 1) apoptosis inducers such as curcumin, gallic acid, resveratrol, Theranekron D6, and gaillardin; 2) topoisomerase inhibitors such as camptothecins, scaffold-hopped flavones, podophyllotoxin, oxocrebanine, and evodiamine derivatives; 3) telomerase inhibitors such as camptothecin and isoquinoline alkaloids of Chelidonium majus, amentoflavone, and emodin; 4) microtubule inhibitors such as kolaflavanone, tanshinone IIA analog, eugenol, and millepachine; 5) immunomodulators such as fucoidan, myricetin, bergapten, and atractylenolide I; 6) tumor microenvironment regulators such as beta-escin and icaritin; 7) multidrug resistance reversal agents such as berberine, quercetin, and dihydromyricetin; and 8) antiangiogenic and antimetastatic agents such as epigallocatechin-3-gallate, lupeol, ononin, and saikosaponin A. Conclusion: Anticancer natural product technology was introduced earlier, but the later development momentum was insufficient. In addition, scientific research activities are relatively closed, and technical exchanges need to be strengthened. Currently, the development of medicinal plants and the research on the anticancer mechanism of natural active products are still research hotspots, especially those related to immune checkpoints, essential oils, and metastatic cancer. Theories of traditional Chinese medicine (TCM), such as "restraining excessiveness to acquire harmony," "same treatment for different diseases," "Meridian induction theory," and "Fuzheng Quxie," have important guiding significance to the research of anticancer mechanisms and the development of new drugs and can provide new ideas for this process. Systematic Review Registration: [https://sourceforge.net/projects/citespace/], identifier [000755430500001].
引用
- Shen J, Li J, Yu P, et al. Research Status and Hotspots of Anticancer Natural Products Based on the Patent Literature and Scientific Articles. Front Pharmacol. 2022. PMID: 35784720. doi:10.3389/fphar.2022.903239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。